Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Liesbeth Heyndrickx"'
Autor:
Sandy Adjemian, Teodora Oltean, Sofie Martens, Bartosz Wiernicki, Vera Goossens, Tom Vanden Berghe, Benjamin Cappe, Maria Ladik, Franck B. Riquet, Liesbeth Heyndrickx, Jolien Bridelance, Marnik Vuylsteke, Katrien Vandecasteele, Peter Vandenabeele
Publikováno v:
Cell Death and Disease, Vol 11, Iss 11, Pp 1-15 (2020)
Abstract Radiotherapy is commonly used as a cytotoxic treatment of a wide variety of tumors. Interestingly, few case reports underlined its potential to induce immune-mediated abscopal effects, resulting in regression of metastases, distant from the
Externí odkaz:
https://doaj.org/article/31ca415bc1864142a05906ae6e07ca1b
Autor:
Tania Løve Aaes, Agnieszka Kaczmarek, Tinneke Delvaeye, Bram De Craene, Stefaan De Koker, Liesbeth Heyndrickx, Iris Delrue, Joachim Taminau, Bartosz Wiernicki, Philippe De Groote, Abhishek D. Garg, Luc Leybaert, Johan Grooten, Mathieu J.M. Bertrand, Patrizia Agostinis, Geert Berx, Wim Declercq, Peter Vandenabeele, Dmitri V. Krysko
Publikováno v:
Cell Reports, Vol 15, Iss 2, Pp 274-287 (2016)
Successful immunogenic apoptosis in experimental cancer therapy depends on the induction of strong host anti-tumor responses. Given that tumors are often resistant to apoptosis, it is important to identify alternative molecular mechanisms that elicit
Externí odkaz:
https://doaj.org/article/12e7c9eabdcf4753a2c5424185446077
Autor:
Sunita S Balla-Jhagjhoorsingh, Betty Willems, Liesbeth Heyndrickx, Leo Heyndrickx, Katleen Vereecken, Wouter Janssens, Michael S Seaman, Davide Corti, Antonio Lanzavecchia, David Davis, Guido Vanham
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25488 (2011)
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtypes have recently been described. Three mAbs, HJ16, HGN194 and HK20, were obtained from patients within the HIV-1 cohort of the Institute of Tropical M
Externí odkaz:
https://doaj.org/article/9d87a2f7f0fe4fb2a7565cbd57cd24fa
Autor:
Mathieu J.M. Bertrand, Iris Delrue, Liesbeth Heyndrickx, Wim Declercq, Tinneke Delvaeye, Dmitri V. Krysko, Sandy Adjemian, Agnieszka Kaczmarek, Joachim Taminau, Bram De Craene, Peter Vandenabeele, Tania Løve Aaes, Hanne Verschuere, Bartosz Wiernicki, Geert Berx
Publikováno v:
The Journal of Immunology
Immunogenic cell death (ICD) occurs when a dying cell releases cytokines and damage-associated molecular patterns, acting as adjuvants, and expresses Ags that induce a specific antitumor immune response. ICD is studied mainly in the context of regula
Autor:
Peter Vandenabeele, Agnieszka Kaczmarek, Liesbeth Heyndrickx, Dmitri V. Krysko, Brigitta M. Brinkman
Publikováno v:
The Journal of Pathology. 226:598-608
Intestinal mucositis is a serious complication of cancer chemotherapy and radiotherapy; it frequently compromises treatment and dramatically reduces the quality of life of patients. Different approaches to limit the damage to the intestine during ant
Autor:
Davide Corti, B. Willems, Sunita S. Balla-Jhagjhoorsingh, Michael S. Seaman, David Davis, Katleen Vereecken, Guido Vanham, Leo Heyndrickx, Wouter Janssens, Antonio Lanzavecchia, Liesbeth Heyndrickx
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 10, p e25488 (2011)
PLoS ONE, Vol 6, Iss 10, p e25488 (2011)
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtypes have recently been described. Three mAbs, HJ16, HGN194 and HK20, were obtained from patients within the HIV-1 cohort of the Institute of Tropical M
Autor:
Agnieszka, Kaczmarek, Brigitta M, Brinkman, Liesbeth, Heyndrickx, Peter, Vandenabeele, Dmitri V, Krysko
Publikováno v:
The Journal of pathology. 226(4)
Intestinal mucositis is a serious complication of cancer chemotherapy and radiotherapy; it frequently compromises treatment and dramatically reduces the quality of life of patients. Different approaches to limit the damage to the intestine during ant
Autor:
Olga Krysko, Dmitri V. Krysko, Liesbeth Heyndrickx, Luc Leybaert, Agnieszka Kaczmarek, T Løve Aaes, Peter Vandenabeele, Tinneke Delvaeye, Claus Bachert
Publikováno v:
Cell Death & Disease
CELL DEATH & DISEASE
CELL DEATH & DISEASE
Dear Editor, Doxorubicin is an anthracycline antibiotic, which is used in treatment of cancer and it works by induction of apoptosis in cancerous cells.1 In vivo, apoptotic cells are rapidly cleared preferentially by monocytes and neutrophil migratio
Autor:
Jerzy Woznicki, Peter Vandenabeele, Agnieszka Kaczmarek, Pieter Bogaert, Stefan Magez, Dmitri V. Krysko, Claus Bachert, Nozomi Takahashi, Anje Cauwels, Olga Krysko, Liesbeth Heyndrickx
Publikováno v:
Vrije Universiteit Brussel
Cell Death and Differentiation; Vol 18
Cell Death and Differentiation; Vol 18
Anthracycline antibiotics are inducers of an immunogenic form of apoptosis that has immunostimulatory properties because of the release of damage-associated molecular patterns. To study the mechanisms used by the innate immune system to sense this im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426f6cc07f19387a27aed77470046146
https://researchportal.vub.be/en/publications/c80d0eef-16bb-4f5d-aebd-9a69de7bbf7c
https://researchportal.vub.be/en/publications/c80d0eef-16bb-4f5d-aebd-9a69de7bbf7c